Subtype
Malignant Endometrial Neoplasm
CI-CAN-00008980Explore in graph →
359 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00008980Explore in graph →
Clinical trials
1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (112)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04845425 | Analysis of miRNA Expression in Endometrial Cancer(MIRCE) | unknown | — | 150 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Jul 21, 2022 | clinicaltrials |
| NCT04873206 | Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies | completed | — | 80 | Sohag UniversityOTHER | 1 | Jul 15, 2022 |
| clinicaltrials |
| NCT01470677 | Tachosil for the Prevention of Symptomatic Lymph Cysts | completed | Phase 3 | 220 | Ruhr University of BochumOTHER | 2 | Jul 8, 2022 | clinicaltrials |
| NCT05448586 | Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? | completed | — | 132 | Instituto de Investigación Hospital Universitario La PazOTHER | 1 | Jul 7, 2022 | clinicaltrials |
| NCT03827837 | Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors | unknown | Phase 2 | 265 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT03834571 | Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women | withdrawn | Phase 2 | 0 | AIDS Malignancy ConsortiumNETWORK | 2 | Jun 21, 2022 | clinicaltrials |
| NCT01672892 | Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer | completed | Phase 3 | 289 | Radiation Therapy Oncology GroupNETWORK | 4 | Jun 15, 2022 | clinicaltrials |
| NCT03077698 | An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer | terminated | Phase 2 | 25 | Xenetic Biosciences, Inc.INDUSTRY | 1 | Jun 7, 2022 | clinicaltrials |
| NCT04178460 | A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment | terminated | Phase 1 | 60 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 1 | Jun 1, 2022 | clinicaltrials |
| NCT05387460 | Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer | unknown | — | 2,000 | Tongji HospitalOTHER | 1 | May 24, 2022 | clinicaltrials |
| NCT04866394 | Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS(SPARTACUS) | unknown | N/A | 40 | Sunnybrook Health Sciences CentreOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03372720 | Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors | completed | N/A | 19 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT00376844 | External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer(PORTEC-2) | completed | Phase 3 | 427 | Leiden UniversityOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT03924245 | Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers | terminated | Phase 1 | 3 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 4, 2022 | clinicaltrials |
| NCT02646748 | Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors | completed | Phase 1 | 159 | Incyte CorporationINDUSTRY | 1 | Mar 31, 2022 | clinicaltrials |
| NCT05290415 | Host DNA Methylation for Endometrial Cancer Screening | unknown | — | 10,000 | Lei LiOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT05290922 | DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening | unknown | — | 7,150 | Lei LiOTHER | 1 | Mar 22, 2022 | clinicaltrials |
| NCT02549209 | Pembro/Carbo/Taxol in Endometrial Cancer | completed | Phase 2 | 46 | Daniela Matei, MDOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT04611139 | Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers | withdrawn | Phase 1 | 0 | HonorHealth Research InstituteOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05261165 | Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | completed | — | 170 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 | clinicaltrials |
| NCT04845828 | Randomized Comparison Between Sentinel Lymph Node Biopsy and Lymph Node Dissection in Early Stage Endometrial Cancer(SELYE) | recruiting | N/A | 810 | Asan Medical CenterOTHER | 1 | Feb 21, 2022 | clinicaltrials |
| NCT03221400 | PEN-866 in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 340 | Tarveda TherapeuticsINDUSTRY | 1 | Feb 17, 2022 | clinicaltrials |
| NCT02728258 | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 11 | NRG OncologyOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT01307631 | Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2022 | clinicaltrials |
| NCT03324958 | VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.(Vire-Brachy) | terminated | N/A | 24 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT03945786 | Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma | suspended | — | 120 | Xuanwu Hospital, BeijingOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | completed | — | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT05121363 | A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma | unknown | Phase 2 | 113 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Nov 30, 2021 | clinicaltrials |
| NCT01512810 | Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer | completed | Phase 2 | 200 | Frederick R. Ueland, M.D.OTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT02315469 | Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery | completed | — | 190 | NRG OncologyOTHER | 2 | Nov 24, 2021 | clinicaltrials |
| NCT03018249 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2021 | clinicaltrials |
| NCT00900562 | Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy | terminated | Phase 2 | 19 | PharmaMarINDUSTRY | 1 | Oct 28, 2021 | clinicaltrials |
| NCT04890912 | Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II(SPARTACUSII) | unknown | N/A | 50 | Sunnybrook Health Sciences CentreOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT05056259 | Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients(PET/CT) | unknown | — | 42 | Assiut UniversityOTHER | 0 | Oct 25, 2021 | clinicaltrials |
| NCT04362046 | Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia(FETCH) | recruiting | N/A | 30 | Vancouver Coastal Health Research InstituteOTHER | 1 | Oct 20, 2021 | clinicaltrials |
| NCT00942357 | Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer | unknown | Phase 3 | 813 | Gynecologic Oncology GroupNETWORK | 3 | Oct 19, 2021 | clinicaltrials |
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab(PROLOG) | completed | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT04290299 | Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive | unknown | — | 100 | National Cancer Institute, NaplesOTHER | 16 | Oct 13, 2021 | clinicaltrials |
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | unknown | — | 10,000 | Tongji HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT02065687 | Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer | unknown | Phase 2 / Phase 3 | 469 | Gynecologic Oncology GroupNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT03962140 | CT Assessment of BMI in Endometrial Cancer Patients | completed | — | 302 | Royal Cornwall Hospitals TrustOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT03463252 | Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC | recruiting | Phase 2 / Phase 3 | 224 | West China Second University HospitalOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT02226302 | Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer(FETCH) | completed | — | 16 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Sep 9, 2021 | clinicaltrials |
| NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer(PRIMMO) | completed | Phase 2 | 43 | University Hospital, GhentOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT05026073 | Vibrational Spectroscopy for Endometrial Cancer Diagnosis(SPEED) | unknown | — | 150 | Nottingham University Hospitals NHS TrustOTHER | 1 | Aug 30, 2021 | clinicaltrials |
| NCT05018195 | Adipocytokines in Endometrial Cancer(ACEmCa) | unknown | N/A | 200 | National Taiwan University HospitalOTHER | 0 | Aug 24, 2021 | clinicaltrials |
| NCT02058550 | Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy | completed | Phase 1 | 72 | Stanford UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04068675 | Effects of Centering Pre-operative Counseling on Patient Reported Anxiety | completed | N/A | 75 | Northwestern UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Jul 21, 2022source: clinicaltrials